AMGN · trading date Oct 12, 2026 · previous close $414.79 · source: Alpaca (IEX feed, not consolidated full-market data).
Key Financials
Revenue
$36.75B
Net income
$7.71B
Total assets
$90.59B
Total liabilities
—
Stockholders' equity
$8.66B
Cash & equivalents
$9.13B
Operating income
$9.08B
Operating cash flow
$9.96B
Capital expenditures
$1.86B
Fiscal year 2025, via 10-K filed 2026-02-13.
A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.
Financial Performance
Operating margin
24.7%
Net margin
21.0%
Free cash flow
$8.10B
Free cash flow margin
22.0%
Liabilities / assets
—
Equity / assets
9.6%
CapEx / revenue
5.1%
Operating cash flow / net income
1.29×
Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.
"Most recent SEC filing" may differ from the filing used for the financial figures above.
Location
Thousand Oaks, CA 91320
ONE AMGEN CENTER DRIVE
Data & Methodology
SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:13 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.